Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Adipose-Neural Axis in Epicardial Fat Drives Cardiac Arrhyth
2026-05-15
Fan et al. (2024) demonstrate that interactions between epicardial adipose tissue and sympathetic neurons, mediated by leptin and neuropeptide Y signaling, are central to the development of cardiac arrhythmias. Their stem cell-based coculture model offers mechanistic insights and highlights potential molecular targets for arrhythmia intervention.
-
WP1066, JAK2/STAT3 Inhibitor: Protocols and Innovations in C
2026-05-14
WP1066 is a potent, cell-permeable JAK2/STAT3 inhibitor enabling precise dissection of oncogenic signaling and immunoregenerative pathways. This article details optimized workflows, key troubleshooting strategies, and practical cross-domain applications to maximize WP1066’s research impact.
-
Bifidobacterium vs FMT: Imaging Neuroinflammation in HE Rats
2026-05-14
This study uses [18F]PBR146 PET imaging to compare the effects of Bifidobacterium and fecal microbiota transplantation (FMT) on neuroinflammation in rats with chronic hepatic encephalopathy (HE). Results reveal that only Bifidobacterium attenuates regional neuroinflammation, underscoring the importance of targeted microbiota interventions and advanced imaging for understanding gut–liver–brain axis mechanisms.
-
MLN2238: Advanced Proteasome β5 Subunit Inhibitor Workflows
2026-05-13
MLN2238 enables high-precision, reversible inhibition of the proteasome β5 subunit, facilitating apoptosis and stress pathway studies in both sensitive and bortezomib-resistant models. Its unique solubility and stability profile, together with robust performance in hematologic malignancy and proteotoxic stress assays, make it a superior choice for oncology and mechanistic research.
-
HOXC8 Represses Pyroptosis in NSCLC via Caspase-1 Suppressio
2026-05-13
This study reveals that HOXC8, a transcription factor overexpressed in NSCLC, prevents pyroptotic cell death by suppressing caspase-1 transcription through recruitment of HDAC1/2. The findings define a new regulatory axis in tumor cell survival and highlight potential intervention points for apoptosis and pyroptosis research.
-
Neuroligin 1 Proteolysis Links Social Memory to Synaptic Rem
2026-05-12
Liu et al. (2025) reveal that social memory maintenance depends on social-interaction-triggered proteolysis of Neuroligin 1 in the ventral hippocampus. Their work uncovers a mechanistic pathway linking secretase-dependent cleavage, NLG1-CTD generation, and cofilin-regulated synaptic plasticity, with broad implications for understanding memory persistence and related neuropsychiatric disorders.
-
Angiotensin 1/2 (5-7): Precision Tool for RAS and Viral Path
2026-05-12
Explore Angiotensin 1/2 (5-7), a high-purity H2N-Ile-His-Pro-OH peptide, as a dual-function research tool in renin-angiotensin system and viral interaction studies. Unlock nuanced insights for protocol design and cross-domain applications.
-
Astrocyte Heterogeneity Atlas: Insights Across Mouse and Mar
2026-05-11
Schroeder et al. provide a comprehensive transcriptomic atlas detailing astrocyte heterogeneity across brain regions and developmental stages in both mouse and marmoset. Their integration of single-nucleus RNA sequencing and expansion microscopy reveals dynamic, region- and species-specific molecular and morphological features, advancing our understanding of glial diversity and specialization.
-
Digestive Biotransformations of Withania somnifera: Metabolo
2026-05-11
This study applies LC–MS/MS profiling and molecular networking to map how bioactive compounds in Withania somnifera extracts are transformed during simulated digestion. The findings improve our understanding of phytochemical stability and transformation, supporting better preclinical assay design for botanical research.
-
UBA1 Regulates Cardiac Hypertrophy via ATG5-Dependent Autoph
2026-05-10
Lin et al. uncover a key molecular mechanism in cardiac hypertrophy: UBA1 promotes disease progression by suppressing autophagy through ubiquitin-mediated degradation of ATG5. This highlights UBA1 as a potential therapeutic target and underscores the importance of protein modification pathways in cardiac remodeling.
-
Proteoform-Specific Drug Targeting in Native Cell Signaling
2026-05-09
This study introduces a native mass spectrometry approach to characterize protein–ligand interactions at the proteoform level within intact cell membranes. By directly analyzing rhodopsin and associated G protein complexes, the research reveals the profound influence of post-translational modifications on drug binding specificity and off-target effects, providing a new framework for rational drug development.
-
Disulfiram (A4015): Mechanisms and Innovations in Cancer Res
2026-05-09
Explore the multifaceted role of Disulfiram as a dopamine β-hydroxylase inhibitor and proteasome modulator in cancer research. This article delivers deep mechanistic insights and practical guidance for advanced researchers, setting itself apart from standard overviews.
-
Cathepsin B inhibitor CA-074: Protocols, QC, and Limitations
2026-05-08
Cathepsin B inhibitor CA-074 (SKU A1926) enables researchers to selectively block cathepsin B activity, supporting studies in cancer metastasis, neurotoxicity, and immune regulation where off-target inhibition is a concern. It should not be used as a non-specific cysteine protease inhibitor where broad-spectrum activity is required, or in workflows demanding prolonged solution stability at room temperature.
-
Optimized Sulfonamide Derivatives Reduce CYP 2C9 Inhibition
2026-05-07
This study demonstrates the rational optimization of sulfaphenazole-derived sulfonamides for potent anti-Mycobacterium tuberculosis activity while minimizing CYP 2C9 inhibition. These findings advance the prospects for safer tuberculosis treatment regimens with reduced risk of drug-drug interactions.
-
Cell Counting Kit-8 Plus: Next-Gen Sensitivity for Oncogenic
2026-05-07
Explore how Cell Counting Kit-8 Plus accelerates sensitive, reliable cell proliferation and cytotoxicity assays, uniquely contextualized for advanced oncology research. Discover mechanistic insights and practical assay guidance in this in-depth scientific resource.